PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC
Clinical trial NCT04974281 · UNKNOWN
Trial details
- NCT number
- NCT04974281
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.